Search company, investor...

Jubilant Chemsys

Founded Year



Merger | Merged

About Jubilant Chemsys

Jubilant Chemsys is an integrated chemistry services provider, which supports R&D programs from lead generation to clinical supplies. On July 28th, 2020, Jubilant Chemsys merged with Jubilant Biosys.

Headquarters Location

B-34, Sector -58

Noida, 201301,


Missing: Jubilant Chemsys's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Jubilant Chemsys's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Jubilant Chemsys News

Jubilant Biosys Limited announces the merger with Jubilant Chemsys Limited

Jul 30, 2020

Jubilant Biosys Limited announces the merger with Jubilant Chemsys Limited BENGALURU, India, July 28, 2020 /PRNewswire/ -- Jubilant Biosys Limited ("Biosys"), a wholly owned subsidiary of Jubilant Life Sciences Limited, today announced completion of the merger with its sister company Jubilant Chemsys Limited, based in Noida, India. The combined entities will now operate as Jubilant Biosys Limited. The merger will simplify operations and provide customers with a single brand access for a wide range of discovery, IND and PR&D and GMP development services. Biosys had earlier announced significant investment in building new state-of-the-art research facilities in Greater Noida and in Bengaluru, India to cater to increasing customer demand for its functional services (medicinal & synthetic chemistry, structural biology, DMPK, Biology & GMP scale-up) and notably integrated drug discovery services. Marcel Velterop, President- Jubilant Biosys Limited and CDMO, said: "We are delighted to make this merger happen and focus our investments for growth to expand both the chemistry as well as integrated drug discovery capabilities. It provides clarity to customers and enables us to better deliver on our '4D' promise of accelerating the discovery process through increased digitization of our operations and information flow." About Jubilant Biosys Limited: Jubilant Biosys, a Bengaluru based wholly owned subsidiary of Jubilant Life Sciences Ltd, offers contract research & development services for global pharmaceutical innovators. Biosys has demonstrated expertise in functional services such as Biology, DMPK, Toxicology as well as Medicinal Chemistry, PR&D and GMP scale-up capabilities up to phase II. It has a proven track record of delivering over 75 integrated programs in multiple therapeutic areas including but not limited to Oncology, Metabolic Disorders, Pain & Inflammation, CNS and expanding into Rare Diseases. Its sister company, TrialStat Solution Inc., provides an advanced EDC platform to accelerate clinical trials' data capture and processing. For more info, please visit . For more information, please contact: Drishti  Asthana,Jubilant Biosys Limited ,Ph: +91- 9899033635,E-mail: Editor Details

Jubilant Chemsys Frequently Asked Questions (FAQ)

  • When was Jubilant Chemsys founded?

    Jubilant Chemsys was founded in 2000.

  • Where is Jubilant Chemsys's headquarters?

    Jubilant Chemsys's headquarters is located at B-34, Sector -58, Noida.

  • What is Jubilant Chemsys's latest funding round?

    Jubilant Chemsys's latest funding round is Merger.

  • Who are the investors of Jubilant Chemsys?

    Investors of Jubilant Chemsys include Jubilant Biosys.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.